Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.05T
| $4.31B | 3.95% |
137,385,124
-2,606,920
| -2% | -$83.4M |
|
2
Meta Platforms (Facebook)
META
$1.51T
| $2.66B | 2.44% |
31,066,834
-851,123
| -3% | -$69.5M |
|
3
Amazon
AMZN
$2.49T
| $2.4B | 2.2% |
110,349,500
+4,660,780
| +4% | +$97.4M |
|
4
Mastercard
MA
$499B
| $2.39B | 2.19% |
25,560,493
-1,252,331
| -5% | -$115M |
|
5
Alphabet (Google) Class C
GOOG
$4.14T
| $2.22B | 2.03% |
83,602,860
-1,100,857
| -1% | -$29.5M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $2.06B | 1.89% |
6,787,114
-199,559
| -3% | -$59.5M |
|
7
Biogen
BIIB
$30.7B
| $1.96B | 1.8% |
4,848,097
-247,504
| -5% | -$99.3M |
|
8
Nike
NKE
$63.8B
| $1.83B | 1.68% |
33,955,704
-24,428
| -0.1% | -$1.25M |
|
9
Bristol-Myers Squibb
BMY
$129B
| $1.83B | 1.68% |
27,475,042
-1,145,460
| -4% | -$75.5M |
|
10
Netflix
NFLX
$306B
| $1.68B | 1.54% |
179,452,700
+8,734,530
| +5% | +$73.1M |
|
11
Starbucks
SBUX
$118B
| $1.56B | 1.43% |
29,175,470
+4,648,138
| +19% | +$236M |
|
12
Visa
V
$697B
| $1.55B | 1.42% |
23,078,210
-894,661
| -4% | -$60.6M |
|
13
Walt Disney
DIS
$171B
| $1.55B | 1.42% |
13,569,486
-195,034
| -1% | -$21.4M |
|
|
SHPG
14
DELISTED
Shire pic
SHPG
| $1.44B | 1.32% |
5,978,513
+162,635
| +3% | +$40.3M |
|
15
Illumina
ILMN
$29.5B
| $1.35B | 1.24% |
6,367,887
-99,052
| -2% | -$19.3M |
|
16
Salesforce
CRM
$154B
| $1.33B | 1.22% |
19,058,911
-2,211,004
| -10% | -$157M |
|
|
LNKD
17
DELISTED
LinkedIn Corporation
LNKD
| $1.32B | 1.21% |
6,370,624
+117,059
| +2% | +$26.1M |
|
18
Boeing
BA
$171B
| $1.31B | 1.2% |
9,420,842
-490,215
| -5% | -$71.5M |
|
|
RHT
19
DELISTED
Red Hat Inc
RHT
| $1.21B | 1.11% |
15,936,231
-435,375
| -3% | -$33.5M |
|
20
Tesla
TSLA
$1.2T
| $1.17B | 1.08% |
65,618,745
-405,285
| -0.6% | -$6.41M |
|
21
Adobe
ADBE
$105B
| $1.17B | 1.07% |
14,473,085
-343,778
| -2% | -$26.8M |
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $1.12B | 1.02% |
9,636,427
-3,525,188
| -27% | -$403M |
|
23
Gilead Sciences
GILD
$166B
| $1.09B | 1% |
9,283,464
-394,099
| -4% | -$43.1M |
|
|
NVO
24
Novo Nordisk
NVO
$228B
| $1.08B | 0.99% |
39,613,144
-7,210,954
| -15% | -$203M |
|
25
Booking.com
BKNG
$157B
| $1.08B | 0.99% |
23,439,125
-1,608,875
| -6% | -$76.8M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.